Christopher Morabito

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Ben Harshbarger, as attorney-in-fact for Christopher Morabito
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Morabito:

Company Role Class Num Shares Value Price $ Report Date Ownership
Astria Therapeutics, Inc. Chief Medical Officer Common Stock 0 $0 $13.59 01 Apr 2024 Direct
Astria Therapeutics, Inc. Chief Medical Officer Stock Option (Right to Buy) 262,500 21 Mar 2025 Direct
Fulcrum Therapeutics, Inc. Chief Medical Officer Stock Option (right to buy) 59,744 19 Jan 2022 Direct

Insider Reports Filed by Christopher Morabito

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ATXS Astria Therapeutics, Inc. 21 Mar 2025 1 $0 4 Chief Medical Officer 25 Mar 2025, 16:05
ATXS Astria Therapeutics, Inc. 01 Apr 2024 3 -$97,239 4 Chief Medical Officer 03 Apr 2024, 16:05
ATXS Astria Therapeutics, Inc. 08 Feb 2024 1 $0 4 Chief Medical Officer 12 Feb 2024, 16:06
ATXS Astria Therapeutics, Inc. 26 Jan 2024 6 -$72,664 4 Chief Medical Officer 30 Jan 2024, 17:03
ATXS Astria Therapeutics, Inc. 02 Jun 2023 1 $0 4 Chief Medical Officer 06 Jun 2023, 08:04
ATXS Astria Therapeutics, Inc. 01 Aug 2022 1 $0 4 Chief Medical Officer 02 Aug 2022, 08:51
ATXS Astria Therapeutics, Inc. 14 Jul 2022 0 $0 3 Chief Medical Officer 15 Jul 2022, 08:20
FULC Fulcrum Therapeutics, Inc. 19 Jan 2022 1 $0 4 Chief Medical Officer 21 Jan 2022, 15:15
FULC Fulcrum Therapeutics, Inc. 28 Jun 2021 1 +$10,076 4 Chief Medical Officer 29 Jun 2021, 16:16
FULC Fulcrum Therapeutics, Inc. 10 May 2021 1 $0 4 Chief Medical Officer 12 May 2021, 16:30
FULC Fulcrum Therapeutics, Inc. 10 May 2021 0 $0 3 Chief Medical Officer 12 May 2021, 16:15